CRABP-I (Cellular Retinoic Acid-Binding Protein I) activators belong to a specific chemical class that interacts with and modulates the activity of CRABP-I proteins within biological systems. CRABP-I is a key member of the cellular retinoic acid-binding protein family, primarily involved in the intracellular transport and modulation of retinoic acid, a metabolite of vitamin A. CRABP-I activators are characterized by their ability to bind to CRABP-I, which subsequently triggers a conformational change in the protein's structure. This conformational alteration is believed to impact the binding affinity of CRABP-I for retinoic acid molecules.
By influencing the conformation of CRABP-I, activators may indirectly impact the cellular retinoic acid signaling pathway. The intricate interplay between CRABP-I, its ligands, and the activators is thought to have implications for cellular differentiation, proliferation, and other vital physiological processes. The precise mechanisms by which CRABP-I activators modulate the protein's function are still a subject of ongoing research, as scientists strive to unravel the complex molecular interactions that underlie this class of compounds.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Used to treat acute promyelocytic leukemia, arsenic trioxide affects various cellular pathways. It has been suggested to modulate retinoic acid signaling and potentially impact CRABP-I expression. | ||||||